Immunome Inc

NASDAQ:IMNM   11:05:29 AM EDT
22.60
-1.68 (-6.92%)
Earnings Announcements

Immunome Reports Q4 Loss Per Share $0.40

Published: 03/25/2021 21:44 GMT
Immunome Inc (IMNM) - Immunome Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update.
Q4 Loss per Share $0.40.
As of Dec 31, 2020, Cash and Cash Equivalents Totaled $39.8 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.41

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.